Antibody-drug Conjugates (ADC)

N-Boc-cis-4-hydroxy-L-proline is a non-cleavable linker designed for use in the synthesis of antibody-drug conjugates (ADCs). This compound features an alkyl chain structure suitable for connecting antibody moieties to various cytotoxic agents, facilitating targeted drug delivery. Additionally, it serves as a versatile PROTAC linker, contributing to the development of proteolysis-targeting chimeras for selective degradation of specific proteins.

Amino-PEG9-acid is a PEG-based linker designed for use in antibody-drug conjugates (ADCs) and PROTACs. This non-cleavable linker facilitates the synthesis of PROTACs and enhances the stability and efficacy of ADC formulations. Its unique properties make it a valuable tool in the development of targeted therapies for various diseases, enabling precise delivery of therapeutic agents to specific cellular targets.

m-PEG6-azide is a non-cleavable polyethylene glycol (PEG) linker designed for use in the synthesis of antibody-drug conjugates (ADCs). This reagent features an azide functional group, enabling it to participate in click chemistry through copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing molecules. Additionally, m-PEG6-azide can engage in strain-promoted alkyne-azide cycloaddition (SPAAC) with compounds possessing DBCO or BCN groups, making it a versatile tool for ADC development and other bioconjugation applications.

Azide-PEG5-Tos is a cleavable five-unit polyethylene glycol (PEG) linker designed for the synthesis of antibody-drug conjugates (ADCs). It features an azide moiety that enables copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing compounds, as well as facilitating strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with DBCO or BCN functionalized molecules. This reagent is essential for the development of targeted therapeutics and advancing research in bioconjugation strategies.

Mal-C2-NHS ester is a non-cleavable linker that facilitates the synthesis of antibody-drug conjugates (ADCs). This reagent reacts selectively with amine groups, enabling the stable attachment of cytotoxic drugs to antibodies. Its primary application lies in the development of targeted cancer therapies, enhancing the efficacy and specificity of drug delivery systems.

Bz-(Me)Tz-NHS is a methyltetrazine-based click chemistry reagent designed for copper-free click conjugation. This third-generation Click-Linker enables efficient labeling and conjugation of biomolecules with high specificity. Its unique properties make it ideal for applications in bioconjugation, drug delivery, and the development of imaging agents in chemical biology research.

Propargyl-PEG8-NHS ester is a PEG-based linker specifically designed for antibody-drug conjugates (ADCs) and PROTACs. Its primary mechanism involves enabling the synthesis of these bioconjugates through a cleavable linker. This compound features an alkyne group that facilitates click chemistry, specifically the copper-catalyzed azide-alkyne cycloaddition (CuAAc), allowing for efficient conjugation with azide-containing molecules. It is a valuable tool for researchers in drug development and bioconjugation studies.

Propargyl-PEG6-acid is a PEG-based linker primarily utilized in the synthesis of proteolysis-targeting chimeras (PROTACs) and antibody-drug conjugates (ADCs). This cleavable linker facilitates the formation of ADCs and enables targeted protein degradation via a click chemistry reaction, leveraging its alkyne group for copper-catalyzed azide-alkyne cycloaddition (CuAAc). Its versatile applications in chemical biology make it a valuable tool for research in targeted therapeutics and bioconjugation strategies.

alpha-GalNAc-TEG-N3 is a specialized click chemistry reagent designed for efficient bioconjugation. Featuring an azide functional group, it facilitates copper-catalyzed azide-alkyne cycloaddition (CuAAc) for reactive alkyne-containing molecules, as well as strain-promoted alkyne-azide cycloaddition (SPAAC) with DBCO or BCN moieties. This reagent is advantageous for applications in biochemical labeling and molecular imaging, enabling the study of interactions between nucleic acids, proteins, and lipids with high specificity and yield.

H-D-Aha-OH hydrochloride is a click chemistry reagent featuring an azide functional group, facilitating copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing molecules. Additionally, it can participate in strain-promoted alkyne-azide cycloaddition (SPAAC) with DBCO or BCN-modified compounds. This versatile reagent is essential for bioconjugation applications, enabling the efficient labeling and modification of biomolecules in chemical biology studies.

DBCO-PEG4-Val-Cit-PAB-PNP is a cleavable ADC linker that facilitates targeted drug delivery. The Val-Cit moiety is specifically cleaved by Cathepsin B, enabling the release of an amine-containing payload when substituted. The DBCO group allows for efficient click chemistry with azide-bearing compounds, making this linker suitable for various antibody-drug conjugate applications in therapeutic research.

Biotin-PEG2-acid is a non-cleavable linker comprising a two-unit polyethylene glycol (PEG) chain, specifically designed for use in antibody-drug conjugates (ADCs). This versatile reagent facilitates the efficient conjugation of biotin to antibodies, enhancing targeting and therapeutic efficacy. Additionally, Biotin-PEG2-acid can be employed as a component in the synthesis of PROTACs, enabling the development of novel therapeutic agents through targeted protein degradation.

Fmoc-NH-PEG9-CH2CH2COOH is a cleavable linker designed for use in the synthesis of antibody-drug conjugates (ADCs) and PROTACs. This PEG-based compound facilitates the conjugation of therapeutic agents to targeted antibodies, enhancing efficacy and selectivity in drug delivery. Its unique structure allows for the effective modulation of protein degradation pathways, making it valuable for research applications in targeted protein degradation and drug development.

Me-Tet-PEG3-Maleimide is an ADC linker characterized by the presence of three polyethylene glycol (PEG) units and a tetrazine moiety. This compound facilitates a specific inverse electron demand Diels-Alder reaction (iEDDA) with trans-cyclooctene (TCO)-containing compounds, enabling efficient bioconjugation. Additionally, the maleimide functional group exhibits stability in aqueous environments, making this linker suitable for drug delivery applications and the development of antibody-drug conjugates (ADCs).

Biotin-PEG3-aldehyde is a cleavable linker that incorporates a triethylene glycol (PEG) moiety, designed for the synthesis of antibody-drug conjugates (ADCs). This reagent facilitates efficient conjugation by linking biotinylated components to antibodies via an aldehyde, enabling targeted delivery of therapeutics. It is especially valuable in research applications aimed at developing and optimizing ADC formulations for enhanced efficacy and specificity in cancer therapy.

Azetidine-3-carboxylic acid serves as a non-cleavable linker for the synthesis of antibody-drug conjugates (ADCs). Its unique structure is also applicable as an alkyl chain-based PROTAC linker, facilitating the development of proteolysis-targeting chimeras (PROTACs). This compound enhances the stability and functionality of bioconjugates, making it valuable for targeted therapeutic research and development.

N-(5-Hydroxypentyl)maleimide serves as a non-cleavable linker in antibody-drug conjugate (ADC) synthesis. This reagent facilitates the stable attachment of drugs to antibodies, ensuring effective delivery in targeted therapies. It is particularly useful in the development of ADCs such as Gemcitabine-O-Si(di-iso)-O-Mc, enhancing their therapeutic potential in cancer research.

Propargyl-PEG8-NH2 is a PEG-based linker primarily used in antibody-drug conjugates (ADCs) and PROTAC synthesis. This non-cleavable linker enhances the stability of ADCs while facilitating the targeted delivery of therapeutic agents. Additionally, its alkyne functional group allows for copper-catalyzed azide-alkyne cycloaddition (CuAAc), making it a valuable tool in click chemistry applications for bioconjugation and drug development.

Boc-NH-ethyl-SS-propionic acid is a cleavable linker specifically designed for the synthesis of antibody-drug conjugates (ADCs). This compound enables the selective release of cytotoxic agents within targeted cells, enhancing therapeutic efficacy while minimizing off-target effects. Its unique structure facilitates controlled cleavage, making it an essential component in the development of innovative cancer therapies.

m-PEG6-Amine is a PEG-based linker designed for use in the synthesis of PROTACs (Proteolysis Targeting Chimeras) and antibody-drug conjugates (ADCs). This cleavable linker enhances the stability and delivery of therapeutic agents, enabling targeted degradation of specific proteins within cellular systems. m-PEG6-Amine applications include the development of innovative ADCs for cancer therapy and other therapeutic modalities that require precise protein modulation.

11-Azidoundecanoic acid is a click chemistry reagent characterized by its azide functional group, primarily acting as a substrate for lipoic acid ligase (LpIA). This compound facilitates bioconjugation and can be modified through Staudinger ligation or click-chemistry techniques. It also supports copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing molecules, in addition to enabling strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with DBCO or BCN functionalized partners. 11-Azidoundecanoic acid is valuable in research applications requiring precise labeling and bioconjugation strategies.

Biotin-PEG1-azide is a cleavable PEG-based linker designed for use in the synthesis of antibody-drug conjugates (ADCs). This compound features an azide functional group, allowing for efficient coupling through copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing molecules. Additionally, Biotin-PEG1-azide can participate in strain-promoted alkyne-azide cycloaddition (SPAAC) reactions when interacting with DBCO or BCN moieties, facilitating versatile labeling and conjugation strategies in chemical biology and therapeutic applications.

(4S)-4-Hydroxy-D-proline methyl ester hydrochloride functions as a non-cleavable linker in the development of antibody-drug conjugates (ADCs). This compound exhibits key biological activity by facilitating stable covalent attachment between antibodies and cytotoxic agents, enhancing the therapeutic efficacy of ADCs. Additionally, its alkyl chain structure allows for application as a PROTAC linker, aiding in the design and synthesis of proteolysis-targeting chimeras.

PTDA-PEG4-azide is a cleavable 4 unit polyethylene glycol (PEG) linker designed for the construction of antibody-drug conjugates (ADCs). This linker contains an azide functional group, enabling it to participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing molecules. Additionally, PTDA-PEG4-azide can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules featuring DBCO or BCN groups, making it a versatile tool in chemical biology and drug development applications.

N3-PEG4-C2-Pfp ester is a non-cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs). This 4-unit PEG linker features an azide functional group, enabling it to participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) reactions with alkyne-bearing molecules. Additionally, it can engage in strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with DBCO or BCN-containing compounds, making it a versatile choice for bioconjugation applications in chemical biology and drug development.

Boc-Val-Ala-PAB is a cathepsin-cleavable linker specifically designed for use in antibody-drug conjugates (ADCs). This compound facilitates the targeted delivery of therapeutic agents by linking them to monoclonal antibodies, enhancing the selectivity and efficacy of treatment. Its application in ADC development supports research in cancer therapies and targeted drug delivery systems.

Aminoethyl-SS-propionic acid is a cleavable linker specifically designed for antibody-drug conjugate (ADC) synthesis. This compound facilitates the attachment of therapeutic agents to monoclonal antibodies, enabling targeted delivery of cytotoxic drugs to cancer cells. Its unique properties ensure stability in circulation while allowing for controlled release in the tumor microenvironment, making it a valuable tool for cancer research and drug development.

Bis-PEG9-acid is a PEG-based linker designed for use in the synthesis of PROTACs (Proteolysis Targeting Chimeras). This compound features a cleavable structure, making it suitable for the development of antibody-drug conjugates (ADCs). Its unique properties facilitate targeted degradation of proteins, enabling efficient research in drug discovery and therapeutic development.

Azido-PEG4-CH2-Boc functions as a cleavable linker primarily utilized in the synthesis of antibody-drug conjugates (ADCs) and PROTACs. This versatile reagent incorporates a PEG spacer and an azide group, allowing it to participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) as well as strain-promoted alkyne-azide cycloaddition (SPAAC) reactions. Its effective application in the development of novel bioconjugates and protein degradation-based therapeutic strategies makes it a valuable tool in chemical biology and drug development research.

PL1601 (BCN-HS-PEG2-VA-PABC-SG3199) is a versatile drug linker designed for antibody-drug conjugates (ADCs). This compound features a BCN group that facilitates strain-promoted alkyne-azide cycloaddition (SPAAC) with azide-containing molecules, enabling efficient conjugation. Its application in click chemistry enhances the specificity and efficacy of targeted drug delivery systems in various biological research contexts.

diMal-O-CH2COOH is a cleavable ADC linker that facilitates the effective delivery of therapeutic agents to targeted cells. This compound plays a crucial role in antibody-drug conjugates by enhancing the stability and bioavailability of the drug while promoting selective release in the tumor microenvironment. Its unique chemical structure enables efficient conjugation and subsequent cleavage, making it an essential tool for research in targeted cancer therapies.

Biotin-C4-amide-C5-NH2 serves as a cleavable linker for the assembly of antibody-drug conjugates (ADCs). This compound facilitates targeted delivery of cytotoxic agents, enhancing the therapeutic efficacy of ADCs while minimizing off-target effects. Its biotin functionality allows for versatile conjugation strategies, making it a valuable tool in the development of innovative cancer therapies and related research applications.

PC Mal-NHS carbonate ester functions as a cleavable linker in the development of antibody-drug conjugates (ADCs). Its primary activity lies in facilitating the selective attachment of cytotoxic agents to monoclonal antibodies, allowing for targeted delivery to cancer cells. This compound is essential for advancing research in targeted therapies and improving the efficacy of cancer treatments.

NH2-PEG5-OH is a PEG-based linker designed for use in the synthesis of proteolysis-targeting chimeras (PROTACs) and antibody-drug conjugates (ADCs). This non-cleavable linker, incorporating a five-unit polyethylene glycol (PEG) structure, enhances the stability and solubility of biologically active compounds. Researchers utilize NH2-PEG5-OH to facilitate targeted degradation of proteins or deliver cytotoxic agents via ADCs, improving therapeutic efficacy in various applications.

Zuvotolimod is an innovative myeloid cell agonist designed as a compound-linker for antibody-drug conjugates (ADCs). This reagent enhances the efficacy of targeted therapies by promoting immune activation in the tumor microenvironment. Zuvotolimod is valuable in cancer research and the study of hepatitis, facilitating investigations into immune modulation and therapeutic interventions.

Fmoc-Gly-Gly-D-Phe-OH is a cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs). This compound serves as a critical component in the development of targeted therapeutics, facilitating the attachment of cytotoxic agents to antibodies. Fmoc-Gly-Gly-D-Phe-OH exhibits enhanced stability during circulation and selective release of the active drug in target tissues, making it valuable for cancer research and drug delivery applications.

Phe-Lys(Fmoc)-PAB is a cathepsin-cleavable linker designed for use in antibody-drug conjugates (ADCs). This compound facilitates the selective release of cytotoxic payloads upon internalization, enhancing therapeutic efficacy. Its application is particularly valuable in targeted cancer therapies, where precise control over drug release is crucial for minimizing off-target effects and improving patient outcomes.

N3-PEG3-CH2CH2-Boc is a cleavable linker designed for use in PROTAC synthesis, specifically serving as a 3-unit polyethylene glycol (PEG) intermediary. This compound facilitates the formation of antibody-drug conjugates (ADCs) and supports click chemistry applications through its azide group. It readily participates in copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-functionalized molecules and can also engage in strain-promoted alkyne-azide cycloaddition (SPAAC) with DBCO or BCN groups, proving valuable in diverse chemical research applications.

1-Cbz-3-Hydroxyazetidine is a non-cleavable ADC linker designed for the synthesis of antibody-drug conjugates (ADCs). Its structural features facilitate stability and efficacy in targeted drug delivery systems. Additionally, this compound serves as an alkyl chain-based PROTAC linker, making it valuable in the development of proteolysis-targeting chimeras (PROTACs) for enhanced protein degradation studies.

Propargyl-PEG1-SS-PEG1-acid is a cleavable linker designed for use in antibody-drug conjugates (ADCs). This compound features an alkyne group enabling copper-catalyzed azide-alkyne cycloaddition (CuAAc), facilitating efficient conjugation with azide-containing molecules. Its unique structure and properties make it a valuable tool for researchers involved in the development of targeted therapeutics.

Propargyl-PEG6-NHS ester is a cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs) and PROTACs. This PEG-based reagent features an alkyne group that enables copper-catalyzed azide-alkyne cycloaddition (CuAAc), facilitating the conjugation of biomolecules. Its versatility as a click chemistry reagent enhances the development of targeted therapies in chemical biology and drug discovery applications.

Fmoc-N-(2-Boc-aminoethyl)-Gly-OH is a Fmoc-protected glycine derivative designed for use as a linker in antibody-drug conjugate (ADC) synthesis. This reagent facilitates the conjugation of antibodies with cytotoxic agents, enabling targeted delivery of therapeutic compounds. Its structural features make it suitable for various applications in bioconjugation and drug development research.

Fmoc-Hyp(Bom)-OH is a non-cleavable linker specifically designed for the synthesis of antibody-drug conjugates (ADCs). This compound features a unique structure that promotes effective conjugation while maintaining stability in biological systems. Additionally, Fmoc-Hyp(Bom)-OH can serve as an alkyl chain-based linker for the development of proteolysis-targeting chimeras (PROTACs), facilitating targeted protein degradation studies. Its versatile applications make it an essential tool for researchers in the fields of drug development and chemical biology.

DBCO-PEG3-acid is a non-cleavable ADC linker featuring a 3-unit polyethylene glycol (PEG) chain. Its primary mechanism involves the strain-promoted alkyne-azide cycloaddition (SPAAC) with azide-containing molecules, enabling effective conjugation in the synthesis of antibody-drug conjugates (ADCs). This reagent is particularly valuable in therapeutic research applications, facilitating targeted drug delivery and enhancing the pharmacological properties of antibody-based treatments.

PPC-NHS ester is a cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs). This compound facilitates the conjugation of cytotoxic agents to antibodies, enabling targeted delivery and enhancing therapeutic efficacy. Its specific reactivity allows for the stable attachment of drugs while ensuring release under appropriate conditions, making it valuable for development in cancer therapeutics and targeted treatment strategies.

Docosanedioic acid functions as a non-cleavable linker in the development of antibody-drug conjugates (ADCs). Its elongated alkyl chain structure provides robust stability, making it suitable for conjugating therapeutic agents to antibodies. Additionally, this compound serves as an alkyl chain-based PROTAC linker, facilitating the synthesis of proteolysis-targeting chimeras (PROTACs) for targeted degradation in research applications.

Amino-PEG5-C2-acid is a PEG-based linker designed for use in the synthesis of PROTACs and non-cleavable antibody-drug conjugates (ADCs). This compound facilitates the conjugation of active pharmaceutical ingredients to antibodies, thereby enhancing target specificity and therapeutic efficacy. Its unique structure allows for optimal stability and performance in bioconjugation applications, making it a valuable tool for researchers in drug development and targeted therapy.

Mal-EGGGG-PEG8-amide-bis(deoxyglucitol) is a cleavable linker specifically designed for antibody-drug conjugate (ADC) applications. This compound enables the controlled release of therapeutic agents, enhancing the efficacy and specificity of targeted cancer treatments. Its structure facilitates stable conjugation while allowing for timely payload delivery upon internalization by target cells. Researchers can utilize this linker in the development of ADCs for improved tumor-targeting strategies in preclinical studies.

H-L-Tyr(2-azidoethyl)-OH hydrochloride is an unnatural tyrosine derivative designed for use in click chemistry applications. Featuring an azide functional group, this reagent is suitable for copper-catalyzed azide-alkyne cycloaddition (CuAAc) with various alkyne-containing molecules. Additionally, it can facilitate ring strain-promoted alkyne-azide cycloaddition (SPAAC) in reactions involving DBCO or BCN groups, making it a versatile tool for bioconjugation and synthetic biology studies.

DBCO-PEG24-Maleimide is a versatile linker featuring a maleimide group and a DBCO (dibenzocyclooctyne) moiety. This compound is ideal for conjugating thiol-containing biomolecules and facilitates efficient click chemistry reactions with azide-bearing substrates. Its unique structure enables stable linkages, making it suitable for applications in antibody-drug conjugates (ADCs) and other bioconjugation frameworks in chemical biology research.